Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 1 de 1
1.
Exp Dermatol ; 32(5): 678-683, 2023 05.
Article En | MEDLINE | ID: mdl-36602233

The melanocortin 1 receptor (MC1R) gene is considered to be a major determinant of the risk of melanoma. The role of MC1R polymorphisms as predisposing factors for the development of a second primary melanoma is not well established. The present study analyses the characteristics from subjects with certain MC1R variants without any other genetic predisposition, as well as the risk of second primary melanoma associated with these variants. We performed a prospective longitudinal single-centre study based on follow-up information of 402 patients diagnosed with cutaneous melanoma. MC1R gene was sequenced in all subjects. High-risk variants were defined as those previously associated with melanoma (V60L, V92M, I155T, R160W, R163Q and D294H). 253 (63%) patients had at least one predisposing variant. These individuals had higher proportion of red/blonde hair, multiple primary melanomas and first melanoma diagnosis under the age of 60. Second primary melanomas were detected in 28 (3.8%) subjects. Having more than 25 melanocytic nevi was associated significantly to the development of second primary melanomas. A higher proportion of individuals carrying at least one predisposing MC1R variant develop a second melanoma, although statistical significance was not reached. Therefore, some MC1R polymorphisms might determine clinical and histological differences between patients with cutaneous melanoma and may represent a risk factor for second primary melanoma, although more studies are needed.


Melanoma , Neoplasms, Multiple Primary , Skin Neoplasms , Humans , Melanoma/genetics , Skin Neoplasms/pathology , Receptor, Melanocortin, Type 1/genetics , Prospective Studies , Phenotype , Risk Factors , Genetic Predisposition to Disease , Melanoma, Cutaneous Malignant
...